2096 — Simcere Pharmaceutical Cashflow Statement
0.000.00%
- HK$14.58bn
- HK$13.94bn
- CNY6.61bn
- 71
- 40
- 40
- 48
Annual cashflow statement for Simcere Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1,082 | 805 | 1,402 | 886 | 740 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 84.2 | -213 | -1,072 | 97.5 | 58.4 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -556 | -718 | -784 | 86.7 | -957 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 773 | 96.7 | -202 | 1,354 | 151 |
Capital Expenditures | -508 | -353 | -209 | -678 | -980 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -85.3 | 882 | -226 | 746 | 2,068 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -593 | 529 | -436 | 68.3 | 1,088 |
Financing Cash Flow Items | -1,571 | -996 | 245 | -46 | -35.5 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1,013 | 2,354 | -1,625 | -754 | -895 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -833 | 2,915 | -2,297 | 684 | 349 |